Sorry, this is not a mid-term 10-bagger. Nothing even approaching it. Remember that the market cap of this company is now 300 million. 300 million!
There is no way that Ropren sales can begin to justify a valuation like that. FDA approval is still years away, with a full Phase III trial to launch, or possible partnering (and associated revenue dilution).
Anyway, enjoy your holiday in Honkers. What a great spot. I hope you have some Solagran bubble bath handy to soothe your bottom line. I am appropriately jealous.
- Forums
- ASX - By Stock
- SLA
- rest assured
rest assured, page-2
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online